These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
Bridging the gap between histopathology and molecular pathology
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
CiRA, Kyoto University and Astellas - Second Phase Joint Research Agreement Signed for Medical Applications of iPS Cells
Subscribe To Our Newsletter & Stay Updated
